A Rare Haplotype of the RET Proto-Oncogene Is a Risk-Modifying Allele in Hirschsprung Disease
- 1 October 2002
- journal article
- Published by Elsevier in The American Journal of Human Genetics
- Vol. 71 (4) , 969-974
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Cell‐line specific chromatin acetylation at the Sox10–Pax3 enhancer site modulates the RET proto‐oncogene expressionFEBS Letters, 2002
- Segregation at three loci explains familial and population risk in Hirschsprung diseaseNature Genetics, 2002
- Differential activities of the RET tyrosine kinase receptor isoforms during mammalian embryogenesisGenes & Development, 2001
- An intronic nucleotide variant of the RET proto-oncogene causes Hirschsprung disease by interfering with RNA splicingGene Function & Disease, 2000
- A single-nucleotide polymorphic variant of the RET proto-oncogene is underrepresented in sporadic Hirschsprung diseaseEuropean Journal of Human Genetics, 2000
- RET genotypes comprising specific haplotypes of polymorphic variants predispose to isolated Hirschsprung diseaseJournal of Medical Genetics, 2000
- Grb2 binding to the different isoforms of Ret tyrosine kinaseOncogene, 1998
- Expression of RET 3′ splicing variants during human kidney developmentOncogene, 1998
- Diversity of RET proto-oncogene mutations in familial and sporadic Hirschsprung diseaseHuman Molecular Genetics, 1995
- A missense mutation of the endothelin-B receptor gene in multigenic hirschsprung's diseaseCell, 1994